The international industry for Active Pharmaceutical Ingredient (API) manufacturers is a intricate landscape, encompassing numerous regions . The People’s Republic of China currently dominates the output of APIs, followed by India, which is a significant player in both generic API distribution. European firms , particularly in nations like German